BridgeBio Pharma, Inc. EV/Sales

EV/Sales of BBIO for past 10 years: annual, quarterly and twelve month trailing (TTM) including EV/Sales growth rates and interactive chart. Compares the total enterprise value of a company to its sales. It is a more accurate measure of business value, as it takes into account cash and debt on the balance sheet. A company with large cash holdings and no debt will show a significantly lower EV/S than P/S ratio.

Highlights and Quick Summary

Current EV/Sales of BridgeBio Pharma, Inc. is 47.3 (as of December 31, 2021)
  • EV/Sales for the quarter ending September 30, 2022 was 29.26 (a 14.02% increase compared to previous quarter)
  • Year-over-year quarterly EV/Sales decreased by -38.14%
  • Annual EV/Sales for 2021 was 47.3 (a -72.05% decrease from previous year)
  • Annual EV/Sales for 2020 was 169.25 (a Infinity% increase from previous year)
Visit stockrow.com/BBIO for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EV/Sales of BridgeBio Pharma, Inc.

Most recent EV/Salesof BBIO including historical data for past 10 years.

Interactive Chart of EV/Sales of BridgeBio Pharma, Inc.

BridgeBio Pharma, Inc. EV/Sales for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 – 29.26 25.66 35.77 –
2021 47.3 134.75 151.23 398.81 47.3
2020 – – 169.25 0.0 169.25
2019 0.0 0.0 – – 0.0

Business Profile of BridgeBio Pharma, Inc.

Sector: Healthcare
Industry: Biotechnology
© stockrow.com